Nutex Health Stock Soars 11.17% on Q1 Earnings Surge

Nutex Health's stock surged 11.17% in pre-market trading on May 14, 2025, driven by strong financial performance in the first quarter of the year.

Nutex Health reported impressive financial results for the first quarter of 2025, with total revenue soaring 213.8% to $211.8 million compared to $67.5 million in the same period last year. The company's net income turned positive, reaching $14.6 million, a significant improvement from a net loss of $0.4 million in Q1 2024. This financial turnaround was largely attributed to successful arbitration efforts through the Independent Dispute Resolution process, which contributed an additional $105 million in revenue.

The company's hospital division also saw a 20.5% increase in visits, totaling 48,269. Nutex Health maintained a robust financial position with $87.7 million in cash and cash equivalents. The company's gross profit margin reached a record high of 56%, and it generated $51.0 million in net cash from operating activities. These achievements underscore Nutex Health's strong operational efficiency and strategic success in the healthcare sector.